BPC-157 + TB-500 Research Reference

Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.

Researched for: combined tissue repair signaling research

Structural Blend blend Blend verified

Also known as: BPC/TB, BPC157 TB500

Quick Facts

Reference Sizes
10 mg total (5 mg + 5 mg), 20 mg total (10 mg + 10 mg)
Components
BPC-157 + TB-500
Calculator
Preset available
Storage
Use source-label storage wording. Track lot, storage location, and open/reconstitution date.
Solubility
No peer-reviewed mixed-formulation compatibility study

Blend Components

This entry is a multi-compound blend. Each component can be opened individually in the reconstitution calculator.

Component
BPC-157
Calculator Profile
Component
TB-500
Calculator Profile
Open All in Blend Calculator

Component amounts shown are arithmetic starters based on equal distribution. Edit values in the calculator before saving.

Catalog Description

BPC-157 plus TB-500 is one of the most common gray-market peptide blends, usually sold as equal 5 mg + 5 mg or 10 mg + 10 mg vials. Market prevalence and component-specific COAs do not establish therapeutic synergy, sterility, stability, or safety. FDA reviewers reported no human study of TB-500 and only very limited human evidence for BPC-157.

Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.

Research Profile

Half-Life
No fixed-blend pharmacokinetic study
Onset
Not established
Administration Routes (Research)
SC in marketed or community products onlyNo validated clinical route

Reported Research Effects

Reported Research Side Effects

Data source: FDA review, current vendors and COAs, and community market checks

Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.

Research Protocols Reported in the Literature

Research Notes

Current vendors and 2026 COAs consistently confirm 10 mg and 20 mg equal-ratio vials. Reddit protocols are anecdotal and were retained only as a labeled community entry.

Supplementary research context only. Not medical advice or a treatment recommendation.

Sources

FDA 2026 advisory meeting materials for BPC-157 and TB-500 — U.S. Food and Drug Administration
https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026
FDA BPC-157 briefing document — U.S. Food and Drug Administration
https://www.fda.gov/media/193343/download

Suggest a community source

Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.

Related Research Articles

Published articles on this site that mention BPC-157 + TB-500 or one of its catalog aliases.

Related Research Tools

Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.

Scroll to Top